Weekly Recap

Racial Disparities in EVT Access, Forced Exercise Impact on Poststroke Patients, EVT Benefits Within 24 Hour Window

ByNeurologyLive® Staff

March 27th 2021

Neurology News Network for the week ending March 27, 2021.

Risdiplam in Symptomatic SMA, Nusinersen Preserves Swallowing, Ataluren Delays Ambulation in DMD

ByNeurologyLive® Staff

March 20th 2021

Neurology News Network for the week ending March 20, 2021.

FDA Approves NeuroCap EEG Device, Surgical Approaches Advantages Identified, Ocrelizumab Observed in Elders

ByNeurologyLive® Staff

March 13th 2021

Neurology News Network for the week ending March 13, 2021.

Electronic Pill Bottle Improves DMT Adherence, Subcutaneous Cladribine Personalized Dosing Well-Tolerated, MS Fatigue Unchanged Long-Term

ByNeurologyLive® Staff

March 6th 2021

Neurology News Network for the week ending March 6, 2021.

Siponimod Improves Cognitive Processing Speed, Opioid Use for Migraine in Emergency Departments, Reduced Stroke Admissions During Pandemic

ByNeurologyLive® Staff

February 27th 2021

Neurology News Network for the week ending February 27, 2021.

JZP-258 sNDA Accepted, FDA Clears gammaCore nVNS, Prevalence of Seizure Cycles

ByNeurologyLive® Staff

February 20th 2021

Neurology News Network for the week ending February 20, 2021.

FDA Approves Genio OSA Therapy, Improved Motor Function With FUS, Soticlestat Evaluated in Dravet Sydrome

ByNeurologyLive® Staff

February 13th 2021

Neurology News Network for the week ending February 13, 2021.

Rituximab Suppresses Inflammatory Disease in MS, IND Filed for ImmCelz, Laser Ablation Safe in Focal Epilepsy

ByNeurologyLive® Staff

February 6th 2021

Neurology News Network for the week ending February 6, 2021.

FDA Grants BREN-02 Orphan Drug Designation, Memory Preservation in Primary Progressive Aphasia, Phenotypes of MS

ByNeurologyLive® Staff

January 30th 2021

Neurology News Network for the week ending January 30, 2021.

FDA Approves TBI Blood Test, Causal Link Between Smoking and Subarachnoid Hemorrhage, Inconsistencies Across EEG Education

ByNeurologyLive® Staff

January 23rd 2021

Neurology News Network for the week ending January 23, 2021.

Donanemab Shows Decline in Alzheimer, Pfizer DMD Study Launched, REM Not Correlated With Seizures

ByNeurologyLive® Staff

January 16th 2021

Neurology News Network for the week ending January 16, 2021.

FDA Approves EEG System, Neurologic Diagnostic Out-Of-Pocket Costs Rising, Nerivio Safe for Adolescents With Migraine

ByNeurologyLive® Staff

January 9th 2021

Neurology News Network for the week ending January 9, 2021.

Larger Infarct Volume Associated With Poorer Outcomes, Edavarone Shows Efficacy in ALS, DMD Treatment Demonstrates Proof-Of-Concept

ByNeurologyLive® Staff

January 2nd 2021

Neurology News Network for the week ending January 2, 2021.

CBD Transdermal Gel Reduces Seizure Frequency, nVNS Improves Migraine, EDSS Accuracy Improvised

ByNeurologyLive® Staff

December 26th 2020

Neurology News Network for the week ending December 26, 2020.

FDA Approves Shorter-Infusion Ocrelizumab, StrokeViewer Cleared by FDA, Ezogabine Demonstrates Efficacy in ALS

ByNeurologyLive® Staff

December 19th 2020

Neurology News Network for the week ending December 19, 2020.

CBD Effective Regardless of Infantile Spasm History, Fenfluramine Effective in CDD, Wristband Sensor Data May Predict Seizures

ByNeurologyLive® Staff

December 12th 2020

Neurology News Network for the week ending December 12, 2020.

Smartphone PMR Treats Migraine, NMOSD Relapse in Pregnant Women, FDA Grants ALS Agent Orphan Drug Designation

ByNeurologyLive® Staff

December 5th 2020

Neurology News Network for the week ending December 5, 2020.

NDA For INP104 Submitted, Sodium Oxybate Improves Nocturnal RBD, Health-Deficit Accumulation Leads to Cognitive Impairment

ByNeurologyLive® Staff

November 28th 2020

Neurology News Network for the week ending November 28, 2020.

Early Life Working Impacts Cognitive Decline, Cleveland Clinic Awarded NIH Grant, Earlier Treatment More Effective in Parkinson Disease

ByNeurologyLive® Staff

November 21st 2020

Neurology News Network for the week ending November 21, 2020.

Aducanumab Not Recommended by FDA, White Paper on Mechanical Thrombectomy, Status Epilepticus Treatment FDA Approved

ByNeurologyLive® Staff

November 14th 2020

Neurology News Network for the week ending November 14, 2020.

PD GENEration Receives Additional Funding, Continuous Ocrelizumab Effective in Progressive MS, Guidelines for Down Syndrome Published

ByNeurologyLive® Staff

November 7th 2020

Neurology News Network for the week ending November 7, 2020.

Diazepam Granted Fast Track, Nerivio Receives FDA Clearance, Zolmitriptan Gets CRL Following NDA Submission

ByNeurologyLive® Staff

October 31st 2020

Neurology News Network for the week ending October 31, 2020.

JZP-258 Effective to Treat Narcolepsy, Pavel Klein Discusses Telemedicine Limitations, Earlier Focal Epilepsy Diagnosis Shows Benefit

ByNeurologyLive® Staff

October 24th 2020

Neurology News Network for the week ending October 24, 2020.

sNDA Accepted For Rimegepant, FDA Expands Pitolisant Indication, Givinostat Wins Rare Pediatric Disease Designation

ByNeurologyLive® Staff

October 17th 2020

Neurology News Network for the week ending October 17, 2020.

Zolgensma Shows Therapeutic Benefit, Anticholinergic Medications Increase MCI Risk, FDA Issues DRL For Zolmitriptan

ByNeurologyLive® Staff

October 10th 2020

Neurology News Network for the week ending October 10, 2020.

FDA Sends CRL For Diazepam, Insomnia Linked to Cognitive Impairment, Midazolam Underutilized By EMS

ByNeurologyLive® Staff

October 3rd 2020

Neurology News Network for the week ending October 2, 2020.

Sumifilam Improves Alzheimer Biomarkers, Fenfluramine Phase 3 Results, Ozanimod Lowers ARR

ByNeurologyLive® Staff

September 26th 2020

Neurology News Network for the week ending September 26, 2020.

Opicapone Treats Motor Fluctuations, Directional DBS Favored in PD, MRgFUS is Effective as Hand Tremor Treatment

ByNeurologyLive® Staff

September 19th 2020

Neurology News Network for the week ending September 19, 2020.

Pocket Card Treats Status Epilepticus, Pitolisant Shows No Cardiac Signals, SSRIs Associated With Increased Risk of Recurrent Stroke

ByNeurologyLive® Staff

September 12th 2020

Neurology News Network for the week ending September 12, 2020.

Lacosamide Meets Primary End Point, Lemborexant Well-Tolerated in Elders, Cala Trio Reduces Hand Tremor

ByNeurologyLive® Staff

September 5th 2020

Neurology News Network for the week ending September 5, 2020.

Weekly Recap

Racial Disparities in EVT Access, Forced Exercise Impact on Poststroke Patients, EVT Benefits Within 24 Hour Window

Risdiplam in Symptomatic SMA, Nusinersen Preserves Swallowing, Ataluren Delays Ambulation in DMD

FDA Approves NeuroCap EEG Device, Surgical Approaches Advantages Identified, Ocrelizumab Observed in Elders

Electronic Pill Bottle Improves DMT Adherence, Subcutaneous Cladribine Personalized Dosing Well-Tolerated, MS Fatigue Unchanged Long-Term

Siponimod Improves Cognitive Processing Speed, Opioid Use for Migraine in Emergency Departments, Reduced Stroke Admissions During Pandemic

JZP-258 sNDA Accepted, FDA Clears gammaCore nVNS, Prevalence of Seizure Cycles

FDA Approves Genio OSA Therapy, Improved Motor Function With FUS, Soticlestat Evaluated in Dravet Sydrome

Rituximab Suppresses Inflammatory Disease in MS, IND Filed for ImmCelz, Laser Ablation Safe in Focal Epilepsy

FDA Grants BREN-02 Orphan Drug Designation, Memory Preservation in Primary Progressive Aphasia, Phenotypes of MS

FDA Approves TBI Blood Test, Causal Link Between Smoking and Subarachnoid Hemorrhage, Inconsistencies Across EEG Education

Donanemab Shows Decline in Alzheimer, Pfizer DMD Study Launched, REM Not Correlated With Seizures

FDA Approves EEG System, Neurologic Diagnostic Out-Of-Pocket Costs Rising, Nerivio Safe for Adolescents With Migraine

Larger Infarct Volume Associated With Poorer Outcomes, Edavarone Shows Efficacy in ALS, DMD Treatment Demonstrates Proof-Of-Concept

CBD Transdermal Gel Reduces Seizure Frequency, nVNS Improves Migraine, EDSS Accuracy Improvised

FDA Approves Shorter-Infusion Ocrelizumab, StrokeViewer Cleared by FDA, Ezogabine Demonstrates Efficacy in ALS

CBD Effective Regardless of Infantile Spasm History, Fenfluramine Effective in CDD, Wristband Sensor Data May Predict Seizures

Smartphone PMR Treats Migraine, NMOSD Relapse in Pregnant Women, FDA Grants ALS Agent Orphan Drug Designation

NDA For INP104 Submitted, Sodium Oxybate Improves Nocturnal RBD, Health-Deficit Accumulation Leads to Cognitive Impairment

Early Life Working Impacts Cognitive Decline, Cleveland Clinic Awarded NIH Grant, Earlier Treatment More Effective in Parkinson Disease

Aducanumab Not Recommended by FDA, White Paper on Mechanical Thrombectomy, Status Epilepticus Treatment FDA Approved

PD GENEration Receives Additional Funding, Continuous Ocrelizumab Effective in Progressive MS, Guidelines for Down Syndrome Published

Diazepam Granted Fast Track, Nerivio Receives FDA Clearance, Zolmitriptan Gets CRL Following NDA Submission

JZP-258 Effective to Treat Narcolepsy, Pavel Klein Discusses Telemedicine Limitations, Earlier Focal Epilepsy Diagnosis Shows Benefit

sNDA Accepted For Rimegepant, FDA Expands Pitolisant Indication, Givinostat Wins Rare Pediatric Disease Designation

Zolgensma Shows Therapeutic Benefit, Anticholinergic Medications Increase MCI Risk, FDA Issues DRL For Zolmitriptan

FDA Sends CRL For Diazepam, Insomnia Linked to Cognitive Impairment, Midazolam Underutilized By EMS

Sumifilam Improves Alzheimer Biomarkers, Fenfluramine Phase 3 Results, Ozanimod Lowers ARR

Opicapone Treats Motor Fluctuations, Directional DBS Favored in PD, MRgFUS is Effective as Hand Tremor Treatment

Pocket Card Treats Status Epilepticus, Pitolisant Shows No Cardiac Signals, SSRIs Associated With Increased Risk of Recurrent Stroke

Lacosamide Meets Primary End Point, Lemborexant Well-Tolerated in Elders, Cala Trio Reduces Hand Tremor

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

NeuroVoices: Benjamin Tolchin, MD, FAAN, on First-Ever AAN Guidelines for Functional Seizures

Women Physicians Day 2026: Sex-Specific Clinical Considerations in Women With Epilepsy

Late-Breaking CHOICE 2 Data Indicate Alteplase Displayed Improved Stroke Recovery

Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis

Biomarker Data Across Studies Support Disease-Targeted Effects of Valiltramiprosate